For breast cancer, Wenbo Song et al. uncovered that TRIM11 promoted breast carcinoma cell proliferation via modulating serine/threonine kinase 1/glucose transporter 1 (AKT/GLUT1)-associated glycolysis [20]. Here, AKT1 is linked to breast carcinoma.